Advertisement

Multi-Centre Trial of Naproxen and Phenylbutazone in Acute Gout

  • R. A. Sturge
  • J. T. Scott
  • E. B. D. Hamilton
  • S. P. Liyanage
  • A. St. J. Dixon
  • C. Engler
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 76B)

Abstract

There are three drugs in general use in the treatment of acute gout. Colchicine has been in intermittent use since Byzantine times but requires frequent administration and its gastrointestinal side effects too often terminate the treatment before the attack. Phenylbutazone is as effective as colchicine (Freyberg, 1962; Gutman, 1965) and untoward reactions occurring during the treatment of acute gout are rare (Smyth and Percy, 1973), although gastro-intestinal intolerance and fluid retention are predominant among the side effects that occasionally limit its usefulness. Indomethacin in adequate dosage has been shown to be as effective as phenylbutazone (Smyth and Percy, 1973) but unpleasant side effects are not infrequent (Boardman and Hart, 1965). There is therefore need for further exploration of safe and rapid therapy in acute gout, particularly as the sufferers are often relatively young and active members of the community.

Keywords

Rheumatic Heart Disease Acute Gout Ankle Oedema Prostaglandin Synthetase Acute Gouty Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. ACHESON, R. M., AND CHAN, Y.-K. (1969) J. chron. Dis., 21, 543 (New Haven survey of joint diseases. The prediction of serum uric acid in a general population)PubMedCrossRefGoogle Scholar
  2. BOARDMAN, P. L., AND HART, F. DUDLEY (1965) Practitioner, 194, 560 (Indomethacin in the treatment of acute-gout)PubMedGoogle Scholar
  3. CUQ, P. (1973) Scand. J. Rheum., Suppl. 2, 64 (Experience francaise du traitement de la crise de goutte aiguë par le naproxen — C1674)CrossRefGoogle Scholar
  4. DENKO, C.W. (1974)-J. Rheumatol., 1, 222 (A phlogistic function of Prostaglandin-E1 in urate crystal inflammation)PubMedGoogle Scholar
  5. DEODHAR, S.D., DICK, W. C., HODGKINSON, R., AND BUCHANAN, W.W. (1973) Quart. J. Med., 42, 387 (Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis)PubMedGoogle Scholar
  6. FLOWER, R.J., CHEUNG, H.S., AND CUSHMAN, D.W. (1973) Prostaglandins, 4, 325 (Quantitative determination of prostaglandins and malandialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle)PubMedCrossRefGoogle Scholar
  7. FREYBERG, R. H. (1962) Arthr. & Rheum., 4, 624 (Gout)CrossRefGoogle Scholar
  8. GUTMAN, A.B. (1965) Arthr. & Rheum., 8, 911 (The treatment of primary gout: the present status)CrossRefGoogle Scholar
  9. HILL, F. H., HILL, A. G. S., MOWAT, A. G., ANSELL, B. M., MATHEWS, J. A., SEIFERT, M. H., GUMPEL, J. M., AND CHRISTIE, G.A. (1973) Scand. J. Rheum., Suppl. 2, 176 (Multi-centre double-blind cross-over trial comparing naproxen and aspirin in rheumatoid arthritis)CrossRefGoogle Scholar
  10. KOGSTAD, O. (1973) Scand. J. Rheum., Suppl. 2, 159 (A doubleblind cross-over study of naproxen and indomethacin in patients with rheumatoid arthritis)CrossRefGoogle Scholar
  11. ORTEL, R.W., AND NEWCOMBE, D.S. (1974) New Engl. J: Med., 29, 1363 (Acute gouty arthritis and response to colchicine in the virtual absence of synovial fluid leucocytes)CrossRefGoogle Scholar
  12. PHELPS, P., AND MCCARTY, D.J., JR. (1969) Postgrad. Med., 45, 87 (Crystal-induced arthritis)PubMedGoogle Scholar
  13. PHELPS, P., PROCKOP, D. J., AND MCCARTY, D. J. (1966) J. Lab. Clin. Med., 68, 433 (Crystal induced inflammation in canine joints. III. Evidence against bradykinin as a mediator of inflammation)PubMedGoogle Scholar
  14. SMYTH, C. J., AND PERCY, J.S. (1973) Ann. rheum. Dis., 32, 351 (Comparison of indomethacin and phenylbutazone in acute gout)PubMedCrossRefGoogle Scholar
  15. SPILBERG, I. (1974) Arthr. & Rheum., 17, 143 (Urate crystal arthritis in animals lacking Hageman factor)CrossRefGoogle Scholar
  16. TACHEGUCHI, C., AND SIH, C.J. (1972) Prostaglandins, 2, 169 (A rapid spectrophotometry assay for prostaglandin synthetase: application to the study of non-steroidal antiinflammatory agents)CrossRefGoogle Scholar
  17. TALBOTT, J. H. (1976) Arthr. & Rheum., 18, 6 (Suppl.) (It happened on the way to the XIII International Congress on Rheumatology in Kyoto and after I had arrived)Google Scholar
  18. WILLKENS, R. F., CASE, J. B., AND HUIX, F. J. (1975) J. Clin. Pharmacol., 15, 363 (The treatment of acute gout with naproxen)PubMedGoogle Scholar
  19. WILSON, G. M., HUFFMAN, E.R., AND SMYTH, C. J. (1956) Amer. J. Med., 21, 232 (Oral phenylbutazone in the-treatment of acute gouty arthritis)PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • R. A. Sturge
    • 1
  • J. T. Scott
    • 1
  • E. B. D. Hamilton
    • 2
  • S. P. Liyanage
    • 3
  • A. St. J. Dixon
    • 4
  • C. Engler
    • 5
  1. 1.Charing Cross Hospital and Kennedy Institute of RheumatologyLondonUK
  2. 2.King’s College HospitalLondonUK
  3. 3.The London HospitalUK
  4. 4.Royal National Hospital for Rheumatic DiseasesBathUK
  5. 5.Syntex PharmaceuticalsMaidenheadUK

Personalised recommendations